Registered outcomes13

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 13 of 13

List	Outcome	Time frame	Description
Primary	Sendentariness, via OURA ring	Through study completion, daily, an average of 2 years	Amount of sedentary time daily, as measured by the OURA ring's sedentariness metric (energy expenditure of 1.5 metabolic equivalents (METs) or less ).
Primary	Moderate-to-vigorous activity (MVPA), via OURA ring	Through study completion, daily, an average of 2 years	Amount of daily moderate-to-vigorous activity (MVPA), as measured by the OURA ring.
Primary	Light-intensity physical activity (LPA), via OURA ring	Through study completion, daily, an average of 2 years	Amount of daily light-intensity physical activity (LPA), as measured by the OURA ring.
Primary	Sleep duration, via OURA ring	Through study completion, daily, an average of 2 years	Sleep duration as measured by the OURA ring.
Primary	Sleep duration variability	Through study completion, an average of 2 years	The dispersion of daily sleep duration values around a participant's personal average.
Primary	Sleep onset time, via OURA ring	Through study completion, daily, an average of 2 years	Sleep onset time as measured by the OURA ring.
Primary	Sleep onset variability	Through study completion, an average of 2 years	The dispersion of daily sleep onset timing values around a participant's personal average.
Primary	Glucose trends across 2 weeks	2 weeks measurement period at baseline; subsequently at 9 months, and 15 months after baseline measurement	Measured via Continuous Glucose Monitor
Primary	Full blood count	At baseline; subsequently 9 months, and 15 months after baseline measurement	Measured via venous blood collection
Primary	Liver panel	At baseline; subsequently at 9 months, and 15 months after baseline measurement	Measured via venous blood collection
Primary	Renal panel	At baseline; subsequently at 9 months, and 15 months after baseline measurement	Measured via venous blood collection
Primary	Iron studies	At baseline; subsequently at 9 months, and 15 months after baseline measurement	Measured via venous blood collection
Primary	Urine panel	At baseline; subsequently at 9 months, and 15 months after baseline measurement	Measured via urine collection

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07887269/registered

API reference For AI assistants